Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Viridian Therapeutics, Inc. Common Stock | VRDN

AI Analysis of Viridian Therapeutics, Inc. Common Stock

There wasn't too much excitement in Viridian Therapeutics today which only managed to move up 0.05% on the day.

Currently VRDN isn't at a clear support/resistance line that seems tradable. Momentum wise Viridian Therapeutics, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. In the near term it might meet some resistance around the $20.47 price point in the near future.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-